Scott Dunseth Myers, Director at Zentalis Pharmaceuticals, Inc. (ZNTL), bought 21,000 shares at $1.40 ($29K) on 2025-04-30, disclosed to the SEC on 2025-04-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| VRDN | BUY | 2023-03-13 | $160K | — | Filing → |
| CASC | BUY | 2017-08-14 | $21K | — | Filing → |
| CASC | BUY | 2017-05-16 | $11K | — | Filing → |